Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of$ 0.37. This compares to loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 8.11%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 0.45 per share when it actually produced a loss of $0.42, delivering a surprise of 6.67%. Over the last four quarters, th ...